NIH Hands Patent for Brain-Protecting Drug Tech to Startup
Published Date: 5/16/2025
Notice
Summary
The National Center for Advancing Translational Sciences plans to give Neurala Bio, Inc. an exclusive license to use new inventions related to c-Abl tyrosine kinase inhibitors, which could help develop important medicines. This means Neurala gets special rights to make and use these inventions, possibly speeding up drug research and development. The deal affects researchers, companies, and patients waiting for better treatments, with no immediate cost changes announced.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Exclusive Drug Patent License to Neurala
The National Center for Advancing Translational Sciences plans to give Neurala Bio, Inc. an exclusive patent license to inventions for c-Abl tyrosine kinase inhibitor compounds and their use. This could help speed up drug research and development and affect researchers, companies, and patients, and the notice states there are no immediate cost changes announced.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20424, National Cancer Institute; Notice of Meeting
The President's Cancer Panel is holding a free virtual meeting on October 15, 2026, to talk about how GLP-1 medications can help lower cancer risks linked to obesity. Anyone interested can join online or send in comments beforehand. This meeting is a great chance for patients, doctors, and researchers to learn about new ways to fight cancer and improve health.
2026-20365, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings on October 29-30, 2026, to review and evaluate grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists applying for grants in areas like biochemistry, software engineering, and mental health will be affected, with no direct money changes announced but important decisions coming soon.
2026-20151, Notice of NIH Tribal Consultations and Listening Session
The NIH is inviting Tribal leaders and members to join two important meetings and a listening session during the National Congress of American Indians Annual Convention in October 2026. They’ll talk about new health research projects, renewing support for Tribal health centers, and shaping a new Tribal Data Sovereignty Policy. Tribes can also send their thoughts by November 20, 2026, helping shape future health programs and policies.
2026-19804, Submission for OMB Review; 30-Day Comment Request; Generic Clearance for NIH Citizen Science and Crowdsourcing Projects (Office of the Director)
The NIH is asking for approval to keep collecting info from citizen science and crowdsourcing projects, making it easier to gather public input on health research. This affects anyone involved in these projects and invites comments by October 28, 2026. No new costs or big changes, just a smooth way to keep the data flowing for better science!
2026-19718, Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding two closed virtual meetings in October 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and research teams applying for grants should note these dates as they impact funding decisions but don’t involve public attendance.
2026-19719, Center for Scientific Review; Amended Notice of Meeting
The NIH’s Center for Scientific Review is shortening a key meeting from two days to just one day on October 13, 2026, keeping the same 9 a.m. to 6 p.m. hours. This change affects members of the Surgical Sciences and Bioengineering review group and means less time in the room but no public access. No money changes or delays are expected—just a quicker, tighter meeting!
Previous / Next Documents
Previous: 2025-08740, Robert D. Willis Power Rate
Southwestern Power Administration plans to raise the Robert D. Willis hydropower rates by 28.6%, boosting yearly revenue from about $1.28 million to $1.65 million starting August 1, 2025, through September 30, 2027. This change affects customers using power from this project and gives everyone a chance to review and comment before it kicks in. Get ready to check out the details and share your thoughts soon!
Next: 2025-08744, National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting
The National Institute of Arthritis and Musculoskeletal and Skin Diseases is holding a private meeting on August 15, 2025, to review grant applications. This closed session protects sensitive info like personal details and trade secrets. Researchers applying for funding should note this important step in the grant process, but no new rules or money changes are announced.